Author

R. S. Maire

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Perren· 2 shared I. Marinoni· 2 shared A. Chouchane· 1 shared A. Di Domenico· 1 shared A. Kollar· 1 shared B. Wiedenmann· 1 shared C. A. Kunze· 1 shared C. P. Pipinikas· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Perren

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Patient-derived tumoroids of advanced high-grade neuroendocrine neoplasms mimic patient chemotherapy responses and guide the design of personalized combination therapies

S. L. April-Monn, K. Detjen, P. Kirchner, K. Braeutigam, M. A. Trippel, T. Grob, C. Statzer, R. S. Maire, A. Kollar, A. Chouchane, C. A. Kunze, D. Horst, M. C. Sadowski, J. Schrader, I. Marinoni, , A. Perren

The paper develops patient-derived tumoroids to predict chemotherapy responses and identify synergistic drug combinations for high-grade GEP-NEN.

bioRxiv · Dec 10, 2022 · PreprintCancer Biology

Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression

A. Di Domenico, C. P. Pipinikas, R. S. Maire, K. Bräutigam, C. Simillion, M. S. Dettmer, E. Vassella, C. Thirlwell, A. Perren, I. Marinoni

The paper uses DNA methylation profiling to identify cell origins and progression mechanisms in PanNETs, finding distinct epigenetic clusters associated with different cell types and clinical outcomes.

bioRxiv · Apr 8, 2020Cancer Biology